Not only have we been run over by competitors they keep backing over us again and again. They’ve been kneeling and sitting on our necks for years. It’s exactly what we should have done to competitors for years now. Wrong management over and over at Medtronic. Every single “leader” at the regional level and above culpable for being irrelevant. Walk the talk you haven’t. Continuing to get smoked by every competitor. Sell the business already.
-
Make it like cafepharma, but for different industries. Learn more about CompanyUnderground
MDT Diabetes
- Thread starter anonymous
- Start date
-
- Tags
- None
Lucky the boss is fully focused and not distracted by like managing the cardiovascular portfolio or something..... oh wait.
But wait - Sean Lennon was hired as a world-class IT Leader - he will surely save the entire company with his Digital Roadmap : we need to go all-Digital, people - never mind that Sean was fired from Novartis and Abbvie - he deserves a third chance to screw up.
Diabetes management's "plan" is for other manufacturers to have product issues and get a warning letter. Which could happen.
It's a nice profitable business, but so far behind.
Strategy is selling Inpen because nobody wants our pump or CGM. Not profitable. Question. Why isn’t any other company really in the Inpen market? Answer. It’s really not lucrative and not medical devices. Medtronic does medical devices. It’s in its own little world between big pharma and medical supplies. How would you think about having to sell just infusion sets and reservoirs and support that business, but not the device itself? That’s Inpen. It’s going to be a failed and loss leader. It won’t lead to being able to sell more pumps and be relevant in the CGM space. Selling the business to a hedge fund would be more profitable than spending the money to acquire Inpen.
Medtronic please sell the business. Being irrelevant is more embarrassing than failing to compete effectively for years now.
Medtronic please sell the business. Being irrelevant is more embarrassing than failing to compete effectively for years now.
Another FCA...good thing you can’t get fired for not hitting your numbers anymore. You just won’t make any money but, let’s face it, you won’t make any money anyway if you aren’t crushing InPen
Sad. Division is sucking the life out of everything connected to it. Miserable state of affairs. Senior leadership trying to hype products nobody wants is disingenuous. Sad. What part of no finger sticks don’t you get? Too little, too late. Customers have turned the page and moved on years ago.
Another April and trying to ship products to meet year end numbers. Feels like an exercise in futility. Company has fallen so far and so fast. Demand for our products reaching new lows everyday.
Just wait until fy22 starts and they start adding territories...with the exception of a few, everyone’s index goes down making this the hardest working and lowest paid sales force in medtech
This division is as good as sold. I heard through the grapevine members of excom are calling for the sale of diabetes...
Farquhar was bad. Hooman was worse. The combination of recent leadership and the associated mismanagement and missing every opportunity to craft a reasonable strategic direction have steered the diabetes division into an unrecoverable implosion. Some of the top performers have left and accounts are no longer loyal without those ongoing relationships.
Continued mismanagement of the CGM business from personal sensors to IPro sunk the ship. If the correct people had been in place in key positions the diabetes division wouldn’t be the after thought that it is. So sad as this situation was totally preventable. Now it’s too late to recover from. Competitors have enjoyed this free fall. Healthcare providers have lost confidence and their support has shifted to competitor companies.
interested to hear other opinions and assessments.
Continued mismanagement of the CGM business from personal sensors to IPro sunk the ship. If the correct people had been in place in key positions the diabetes division wouldn’t be the after thought that it is. So sad as this situation was totally preventable. Now it’s too late to recover from. Competitors have enjoyed this free fall. Healthcare providers have lost confidence and their support has shifted to competitor companies.
interested to hear other opinions and assessments.
This is the 4th fiscal year in a row that we’re getting crushed on new pumps. InPen is weak.We’re supposed to be a pump and CGM company.
Smaller territories coming...most likely shifting MTM’s to the TM role selling entire portfolio
Broken division. Brainwashed to believe we are still market leaders. The daily grind and volume of work is unbelievable. Not worth the pay. I’m out. Time to pull the rip chord. All the other good reps have already left.
This business sucks! Poor leaders, bad product management, not listening to the customer, and no executive accountability. But, management being paid on fostering a “woke” environment and hiring to meet quotas. Without a sound business nothing else matters.
the titanic is sinking while the band holds hands and sings kumbaya